Stay up to date with the latest news from Ricoh Biosciences. From breakthroughs in iPSC technology and disease modeling to company milestones, press releases, and scientific collaborations — explore how we’re driving innovation in drug discovery and cell therapy.
Company Updates & Industry Highlights
Elixirgen Scientific, Inc Rebrands as Ricoh Biosciences, Inc, Expanding Global Capabilities to Accelerate Drug Discovery and Development for Partners Worldwide
Elixirgen Scientific Japan Awarded Best CDMO Finalist at Citeline Awards Japan – 2024 by Citeline
Elixirgen Scientific Launches Proprietary In Vitro Assay Service Designed for Rett Syndrome
Elixirgen Scientific and Mitsubishi Tanabe Pharma America Announce a Cell Supply Agreement for the Manufacturing of Human iPSC-Derived CNS Cell Types
Elixirgen Scientific Launches Advanced hiPSC-Derived Disease Panel for Alzheimer’s Disease
Elixirgen Scientific Achieves ISO 9001 Certification, Strengthening Commitment to Excellence in Biotechnology
Elixirgen Scientific Japan Awarded Top 10 CDMOs in APAC 2023
TriLink BioTechnologies® Signs Non-exclusive License and Supply Agreement with Elixirgen Scientific Japan for CleanCap® mRNA capping technology
No results found.
Want to Learn More?
Interested in collaborating, covering our work, or featuring Ricoh Biosciences in your publication? Get in touch with our team.
Contact Us
Have a question about our products, services, or custom projects? Our team is here to help—reach out and we’ll get back to you as soon as possible.
Subscribe
Sign up to our eNewsletter to stay up to date with the latest product launches, promotions, and receive expert tips.
By signing up you are agreeing to our Privacy Policy